Company / Total Debt
NovoCure Ltd Total Debt History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$195.0M
FY2025
5-year range
$97.3M / $568.8M
FY2021-FY2025
Trend
+100.5%
vs FY2024
Sector context
#81 of 102
Health Care
What the data says
NovoCure Ltd's total debt of $195M is lower than 79% of companies in the Health Care sector (FY2025). Improved from $569M to $195M over the past 2 years.
Based on SEC 10-K filings.
$195M in FY2025 with a 5-year CAGR of -14.6%.
Improved from $569M to $195M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -29.9%
- 5-Year CAGR
- -14.6%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 102This company $195.0M Sector average $4.5B
▼
-95.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -14.6%, indicating a declining trend.
- In FY2025, total debt increased 100.5% year-over-year.
- Ranks #81 out of 102 companies in the Health Care sector.
- Peak total debt was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $195.0M | +100.5% |
| FY2024 | $97.3M | -82.9% |
| FY2023 | $568.8M | +0.6% |
| FY2022 | $565.5M | +0.6% |
| FY2021 | $562.2M | +30.8% |
| FY2020 | $429.9M | +187.7% |
| FY2019 | $149.4M | +0.1% |
| FY2018 | $149.3M | +53.3% |
| FY2017 | $97.3M | +1.2% |
| FY2016 | $96.2M | +316.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026